Andrew Koff

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion”.

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

Cancer Cell(2024)10.1016/j.ccell.2024.10.013

N/A

0.416DataRank · unranked

15 citations

Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R. Dry, Hong Shao +22 more

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1726

N/A

0DataRank · unranked

166 citations

Baishan Jiang, Jiaye Guo, Hong Shao, Isabella Del Priore, Qing Chang +20 more

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2378

N/A

0DataRank · unranked

36 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

Cancer Cell(2024)10.1016/j.ccell.2024.09.009

N/A

0DataRank · unranked

49 citations

Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R. Dry, Hong Shao +23 more

Data from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

(2024)10.1158/1078-0432.c.7077823.v1

N/A

0DataRank · unranked

0 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more